In the previous articles of our Beyond FDA series, we explored nine realities that many Healthcare AI companies discover too late: FDA clearance does not guarantee market adoption. Great products fail without a reimbursement strategy. AI accuracy alone is no longer enough. Clinical validation is what earns trust. Trust itself comes from Key Opinion Leaders, not marketing. Clearance, validation, and adoption are three separate pillars that must be earned independently. The best algorithm still loses to the best-integrated one. CIOs buy risk reduction before they buy innovation. Even a validated, cleared tool can stall waiting for PACS and EHR governance approval. And ACR alignment is becoming a real competitive advantage in radiology AI. That last point raises an obvious follow-up question. One most vendors answer incorrectly: What does "ACR alignment" actually mean beyond detection accuracy?
(Beyond FDA Series, Part 10)
The Detection Trap
Ask most AI vendors how their product aligns with ACR standards, and the answer almost always comes back to performance: sensitivity, specificity, detection rate compared to a benchmark dataset. That's a reasonable place to start, and it's also where most vendors stop.
ACR standards were never only about whether a finding gets detected. They're about how radiology actually practices, end to end. Vendors who treat "ACR-aligned" as synonymous with "detects things accurately" are missing most of what the standard actually covers.
What Gets Missed
✔ Reporting structure: ACR-aligned practice expects findings to slot into standardized reporting language and structure (e.g., BI-RADS, Lung-RADS style categorical frameworks), not a vendor's own proprietary output format
✔ Workflow placement: where in the radiologist's read does the AI output appear, and does it match how they already triage and prioritize studies, rather than adding a parallel review step
✔ Appropriateness criteria fit: does the tool's use case align with when and why a given study is ordered in the first place, per ACR Appropriateness Criteria, or does it operate as if every study is equally relevant
✔ Quality and audit trail expectations: ACR practice parameters assume a level of documentation and quality oversight that many AI outputs aren't built to support out of the box
A tool can post excellent detection numbers and still fail on all four of these, and that mismatch is exactly what shows up as radiologist friction during a pilot.
Why This Gap Persists
Most AI companies are built by technical teams optimizing for a metric they can measure precisely: model performance against a labeled dataset. Reporting conventions, workflow placement, and appropriateness fit are harder to quantify, so they get deprioritized, even though they're what a working radiologist actually experiences first.
The result is a familiar pattern: a technically strong tool arrives for a pilot, performs well on detection, and still generates complaints, not about accuracy, but about how much it disrupts an established reading routine.
Closing the Gap
Vendors correcting for this tend to do a few things early, not after a failed pilot:
-
Involve practicing radiologists in output design, not just validation, specifically on reporting format and where results surface
-
Map the tool's use case explicitly against ACR Appropriateness Criteria before pitching a department, so the "why this, why now" question is already answered
-
Build outputs that slot into existing structured reporting templates rather than requiring radiologists to translate between two systems
None of this requires new AI capability. It requires treating clinical workflow fit as seriously as model performance.
Final Thought
Detection accuracy answers "did the AI find it?"
ACR-aligned practice answers "does this fit how radiology actually works?"
Accuracy proves the model.
Workflow fit proves the vendor understands the profession.
Vendors chasing ACR alignment purely through better detection metrics are solving the part of the problem radiologists already assume is solved. The differentiation is in the part most vendors still overlook.
Next in the Beyond FDA Series:
PCCP May Be The Biggest Regulatory Shift In Healthcare AI Since 510(k)
#HealthcareAI #ACR #RadiologyAI #ClinicalWorkflow #MedicalImaging #DigitalHealth #HealthcareInnovation #ArtificialIntelligence #MedTech #SaMD #QscriptionTechnologies